HPi2 Antikörper
-
- Target
- HPi2 (HPI2) (Hepatic PMN Infiltration 2 (HPI2))
- Reaktivität
- Human
- Wirt
- Maus
- Klonalität
- Monoklonal
- Applikation
- Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Flow Cytometry (FACS), Immunofluorescence (IF)
- Spezifität
- Reacts with human HPi2 protein (specific for multiple endocrine cell types)
- Aufreinigung
- Cell culture supernatant
- Immunogen
- Human pancreatic enriched islet cells containing low levels of exocrine and ductal cells.
- Klon
- HIC1-2B4-2B
- Isotyp
- IgG1
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- FC : 1/50 to 1/100 - IHC - F : 1/100 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- DMEM, 10 % FBS + supplements., Sodium azide 0.09 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
- Target
- HPi2 (HPI2) (Hepatic PMN Infiltration 2 (HPI2))
- Andere Bezeichnung
- HPi2
- Hintergrund
- Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.
-